Antitumor polycyclic acridines. 8.(1) Synthesis and telomerase-inhibitory activity of methylated pentacyclic acridinium salts.
暂无分享,去创建一个
Charles A Laughton | Chetna Modi | C. Laughton | L. Kèlland | M. Stevens | S. Gowan | R. Heald | J. Cookson | Ian Hutchinson | Malcolm F G Stevens | Robert A Heald | Jenny C Cookson | Sharon M Gowan | Lloyd R Kelland | I. Hutchinson | Chetna Modi | L. Kelland
[1] J. Mergny,et al. Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[2] M. Searle,et al. Recognition and stabilization of quadruplex DNA by a potent new telomerase inhibitor: NMR studies of the 2:1 complex of a pentacyclic methylacridinium cation with d(TTAGGGT)4 , 2001 .
[3] M. Stevens,et al. Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes. , 2001, Molecular pharmacology.
[4] T. Lange. Telomere Capping--One Strand Fits All , 2001 .
[5] Stephen Neidle,et al. Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[6] J. Mergny,et al. Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[7] J. Mergny,et al. Ethidium derivatives bind to G-quartets, inhibit telomerase and act as fluorescent probes for quadruplexes. , 2001, Nucleic acids research.
[8] E. Blackburn,et al. Telomere states and cell fates , 2000, Nature.
[9] M. Blasco,et al. Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis , 2000, Nature Genetics.
[10] L. Kèlland,et al. Telomerase inhibitors: targeting the vulnerable end of cancer? , 2000, Anti-cancer drugs.
[11] D. Maciejewska,et al. 1H, 13C and 15N NMR and GIAO CPHF calculations on two quinoacridinium salts , 2000 .
[12] M. Stevens,et al. Antitumor polycyclic acridines. 7. Synthesis and biological properties of DNA affinic tetra- and pentacyclic acridines. , 2000, Journal of medicinal chemistry.
[13] J. Chaires,et al. Preferential Binding of 3,3‘-Diethyloxadicarbocyanine to Triplex DNA , 2000 .
[14] J. Chaires,et al. Sequence and structural selectivity of nucleic acid binding ligands. , 1999, Biochemistry.
[15] W. Hahn,et al. Inhibition of telomerase limits the growth of human cancer cells , 1999, Nature Medicine.
[16] M. Robinson,et al. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. , 1999, Genes & development.
[17] S. Neidle,et al. Human telomerase inhibition by substituted acridine derivatives. , 1999, Bioorganic & medicinal chemistry letters.
[18] S. Neidle,et al. Design, synthesis and evaluation of human telomerase inhibitors based upon a tetracyclic structural motif. , 1999, Anti-cancer drug design.
[19] S. Neidle,et al. Telomerase as an anti-cancer target: current status and future prospects. , 1999, Anti-cancer drug design.
[20] Robert A. Weinberg,et al. Creation of human tumour cells with defined genetic elements , 1999, Nature.
[21] S. Neidle,et al. 2,7-Disubstituted amidofluorenone derivatives as inhibitors of human telomerase. , 1999, Journal of medicinal chemistry.
[22] J. Shay,et al. Role of telomerase in cellular proliferation and cancer , 1999, Journal of cellular physiology.
[23] C. Laughton,et al. Molecular recognition between a new pentacyclic acridinium salt and DNA sequences investigated by optical spectroscopic techniques, proton nuclear magnetic resonance spectroscopy, and molecular modeling. , 1999, Biochemistry.
[24] E. Raymond,et al. Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells. , 1999, Cancer research.
[25] O. Fedoroff,et al. NMR-Based model of a telomerase-inhibiting compound bound to G-quadruplex DNA. , 1998, Biochemistry.
[26] S. Neidle,et al. 1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase. , 1998, Journal of medicinal chemistry.
[27] Robert A. Weinberg,et al. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues , 1998, Nature Genetics.
[28] R. Wheelhouse,et al. Cationic Porphyrins as Telomerase Inhibitors: the Interaction of Tetra-(N-methyl-4-pyridyl)porphine with Quadruplex DNA , 1998 .
[29] M. Bass,et al. Human telomerase contains evolutionarily conserved catalytic and structural subunits. , 1997, Genes & development.
[30] D A Scudiero,et al. The NCI anti-cancer drug screen: a smart screen to identify effectors of novel targets. , 1997, Anti-cancer drug design.
[31] S. Neidle,et al. Inhibition of human telomerase by a G-quadruplex-interactive compound. , 1997, Journal of medicinal chemistry.
[32] Lea Harrington,et al. A Mammalian Telomerase-Associated Protein , 1997, Science.
[33] G. S. Johnson,et al. An Information-Intensive Approach to the Molecular Pharmacology of Cancer , 1997, Science.
[34] M. Stevens,et al. Antitumour polycyclic acridines. Part 1. Synthesis of7H-pyrido- and 8H-quino-[4,3,2-kl]acridinesby Graebe–Ullmann thermolysis of 9-(1,2,3-triazol-1-yl)acridines:application of differential scanning calorimetry to predict optimumcyclisation conditions , 1997 .
[35] C B Harley,et al. Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.
[36] E. Ciszak,et al. Formation of quinoacridinium system. A novel reaction of quinaldinium salts , 1988 .
[37] G. Reynolds. The Reaction of Organic Azides with Benzyne , 1964 .